| Literature DB >> 35459751 |
Bethan Jones1,2, Sarah Bennett1,3, Ingrid Larsson4,5, Heidi Zangi6,7, Carina Boström8, Kristien Van der Elst9, Françoise Fayet10, Mie Fusama11, María Del Carmen Herrero Manso12, Juliana Rachel Hoeper13,14, Marja Leena Kukkurainen15, Suet Kei Kwok16, Elsa Frãzao-Mateus17, Patricia Minnock18, Tiziana Nava19, Milena Pavic Nikolic20, Jette Primdahl21,22, Roopa Rawat23, Mareen Schoenfelder24,25, Matylda Sierakowska26, Marieke Voshaar27, Edgar Wammervold28, Astrid van Tubergen29,30, Mwidimi Ndosi31,32.
Abstract
OBJECTIVES: To explore patients' agreement and reasons for agreement or disagreement with the EULAR recommendations for patient education (PE) for people with inflammatory arthritis (IA).Entities:
Keywords: arthritis; health services research; patient care team; qualitative research; rehabilitation
Mesh:
Year: 2022 PMID: 35459751 PMCID: PMC9036425 DOI: 10.1136/rmdopen-2022-002256
Source DB: PubMed Journal: RMD Open ISSN: 2056-5933
Characteristics of participants
| Characteristic or variable | N (%) or mean (SD) |
| Sex, N (%) | Female: 2193 (79) |
| Primary diagnosis, N (%) | Rheumatoid arthritis: 1258 (45.2) |
| Age in years | 55.1 (13.1) |
| Disease duration in years | 17.1 (13.3) |
| Highest level of qualification | Certificate: 451 (16) |
SD, Standard deviation.
Number of respondents by country
| Country | Attempted | Completed |
| Austria | 6 | 4 |
| Belgium | 151 | 117 |
| Bulgaria | 1 | 0 |
| Czech Republic | 1 | 0 |
| Denmark | 336 | 310 |
| Estonia | 2 | 1 |
| Finland | 150 | 120 |
| France | 653 | 505 |
| Germany | 9 | 5 |
| Greece | 3 | 2 |
| Hong Kong | 18 | 10 |
| India | 9 | 9 |
| Ireland | 49 | 12 |
| Italy | 304 | 269 |
| Netherlands | 57 | 34 |
| Norway | 405 | 310 |
| Poland | 81 | 62 |
| Portugal | 63 | 49 |
| Slovenia | 9 | 2 |
| Spain | 27 | 20 |
| Sweden | 773 | 690 |
| Switzerland | 2 | 1 |
| UK | 281 | 251 |
| Not noted | 1508 | 0 |
| Total | 4912 | 2779 |
Levels of agreement with each recommendation
| Recommendation | Median (IQR) |
| 1. Patient education should be provided for people with inflammatory arthritis as an integral part of standard care in order to increase patient involvement in disease management and health promotion. | 10 (10–10) |
| 2. All people with inflammatory arthritis should have access to and be offered patient education throughout the course of their disease including as a minimum; at diagnosis, at pharmacological treatment change and when required by the patient’s physical or psychological condition. | 10 (9–10) |
| 3. The content and delivery of patient education should be individually tailored and needs-based for people with inflammatory arthritis. | 10 (9–10) |
| 4. Patient education in inflammatory arthritis should include individual and/or group sessions, which can be provided through face-to-face or online interactions, and supplemented by phone calls, written or multimedia material. | 10 (9–10) |
| 5. Patient education programmes in inflammatory arthritis should have a theoretical framework and be evidence-based, such as self-management, cognitive behavioural therapy or stress management. | 10 (9–10) |
| 6. The effectiveness of patient education in inflammatory arthritis should be evaluated and outcomes used must reflect the objectives of the patient education programme. | 10 (9–10) |
| 7. Patient education in inflammatory arthritis should be delivered by competent health professionals and/or by trained patients, if appropriate, in a multidisciplinary team. | 10 (10–10) |
| 8. Providers of patient education in inflammatory arthritis should have access to and undertake specific training in order to obtain and maintain knowledge and skills. | 10 (10–10) |
IQR, Interquartile range.